Cryomilled zinc sulfide: A prophylactic for Staphylococcus aureus-infected wounds
- Texas Tech Univ. Health Sciences Center, Lubbock, TX (United States). School of Medicine. Dept. of Ophthalmology and Visual Sciences
- Iowa State Univ., Ames, IA (United States). Dept. of Industrial and Manufacturing Systems Engineering
- Univ. of Edinburgh, Scotland (United Kingdom). Inst. for Bioengineering
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Center for Nanophase Materials Science
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Biosciences Division
- Texas Tech Univ. Health Sciences Center, Lubbock, TX (United States). Dept. of Molecular Microbiology and Immunology. Dept. of Surgery
- Texas Tech Univ. Health Sciences Center, Lubbock, TX (United States). School of Medicine
- Iowa State Univ., Ames, IA (United States). Dept. of Industrial and Manufacturing Systems Engineering; Texas Tech Univ. Health Sciences Center, Lubbock, TX (United States). Dept. of Surgery
Bacterial pathogens that colonize wounds form biofilms, which protect the bacteria from the effect of host immune response and antibiotics. This paper examined the effectiveness of newly synthesized zinc sulfide in inhibiting biofilm development by Staphylococcus aureus (S. aureus) strains. Zinc sulfide (ZnS) was anaerobically biosynthesized to produce CompA, which was further processed by cryomilling to maximize the antibacterial properties to produce CompB. The effect of the two compounds on the S. aureus strain AH133 was compared using zone of inhibition assay. The compounds were formulated in a polyethylene glycol cream. We compared the effect of the two compounds on biofilm development by AH133 and two methicillin-resistant S. aureus clinical isolates using the in vitro model of wound infection. Zone of inhibition assay revealed that CompB is more effective than CompA. At 15 mg/application, the formulated cream of either compound inhibited biofilm development by AH133, which was confirmed using confocal laser scanning microscopy. At 20 mg/application, CompB inhibited biofilm development by the two methicillin-resistant S. aureus clinical isolates. To further validate the effectiveness of CompB, mice were treated using the murine model of wound infection. Finally, colony forming cell assay and in vivo live imaging results strongly suggested the inhibition of S. aureus growth.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Energy Efficiency and Renewable Energy (EERE), Energy Efficiency Office. Advanced Manufacturing Office; USDOE Office of Science (SC)
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1435225
- Journal Information:
- Journal of Biomaterials Applications, Vol. 33, Issue 1; ISSN 0885-3282
- Country of Publication:
- United States
- Language:
- English
Similar Records
Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus
Focused ultrasound treatment of abscesses induced by methicillin resistant Staphylococcus aureus: Feasibility study in a mouse model